Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

NCT00367679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Lung Cancer, Non-Small Cell

Interventions

DRUG: Pazopanib

Sponsor

GlaxoSmithKline